The double life of KLF5: Opposing roles in regulation of gene‐expression, cellular function, and transformation
暂无分享,去创建一个
[1] P. Guo,et al. Different Expression Patterns and Functions of Acetylated and Unacetylated Klf5 in the Proliferation and Differentiation of Prostatic Epithelial Cells , 2013, PloS one.
[2] I. Lewis,et al. Methylation of KLF5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival , 2013, British journal of haematology.
[3] J. Whitsett,et al. Klf5 controls bone marrow homing of stem cells and progenitors through Rab5-mediated β1/β2-integrin trafficking , 2013, Nature Communications.
[4] S. Inoue,et al. Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens. , 2012, Endocrine-related cancer.
[5] Yizeng Yang,et al. p53 mutation alters the effect of the esophageal tumor suppressor KLF5 on keratinocyte proliferation , 2012, Cell cycle.
[6] Zhongmei Zhou,et al. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor. , 2012, The American journal of pathology.
[7] Marie-Pier Tétreault,et al. Krüppel-Like Factor 5 Protects against Murine Colitis and Activates JAK-STAT Signaling In Vivo , 2012, PloS one.
[8] Bin Zheng,et al. KLF5 and hhLIM cooperatively promote proliferation of vascular smooth muscle cells , 2012, Molecular and Cellular Biochemistry.
[9] Dar-Ren Chen,et al. Association of Expression of Kruppel-Like Factor 4 and Kruppel-Like Factor 5 with the Clinical Manifestations of Breast Cancer , 2012, Pathology & Oncology Research.
[10] M. Arends,et al. RAS signalling in the colorectum in health and disease , 2012, Cell communication & adhesion.
[11] A. Sepulveda,et al. Loss of transcription factor KLF5 in the context of p53 ablation drives invasive progression of human squamous cell cancer. , 2011, Cancer research.
[12] V. Yang,et al. Krüppel-like factor 5 is important for maintenance of crypt architecture and barrier function in mouse intestine. , 2011, Gastroenterology.
[13] Mei Han,et al. HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs , 2011, Cell Research.
[14] S. Provencher,et al. Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension , 2011, Respiratory research.
[15] V. Yang,et al. The E3 Ubiquitin Ligase SMAD Ubiquitination Regulatory Factor 2 Negatively Regulates Krüppel-like Factor 5 Protein* , 2011, The Journal of Biological Chemistry.
[16] K. Fujiu,et al. Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. , 2011, The Journal of clinical investigation.
[17] J. Whitsett,et al. Kruppel-like factor 5 is required for formation and differentiation of the bladder urothelium. , 2011, Developmental biology.
[18] K. Zhao,et al. Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells. , 2011, The Biochemical journal.
[19] M. Tschan,et al. Deregulated expression of Kruppel-like factors in acute myeloid leukemia. , 2011, Leukemia research.
[20] J. Omichinski,et al. Structural and functional characterization of an atypical activation domain in erythroid Krüppel-like factor (EKLF) , 2011, Proceedings of the National Academy of Sciences.
[21] Zhongmei Zhou,et al. The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. , 2011, Molecular endocrinology.
[22] Yongjian Yang,et al. BTEB2 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model. , 2011, Molecular medicine reports.
[23] J. Whitsett,et al. Conditional disruption of mouse Klf5 results in defective eyelids with malformed meibomian glands, abnormal cornea and loss of conjunctival goblet cells. , 2011, Developmental biology.
[24] Y. Homma,et al. Estrogen Regulates Tumor Growth Through a Nonclassical Pathway that Includes the Transcription Factors ERβ and KLF5 , 2011, Science Signaling.
[25] Yongjian Yang,et al. Overexpression of angiotensin II type 2 receptor suppresses neointimal hyperplasia in a rat carotid arterial balloon injury model. , 2011, Molecular medicine reports.
[26] V. Yang,et al. Krüppel-like factor 5 protects against dextran sulfate sodium-induced colonic injury in mice by promoting epithelial repair. , 2011, Gastroenterology.
[27] V. Yang,et al. Mammalian Krüppel-like factors in health and diseases. , 2010, Physiological reviews.
[28] P. Savatier,et al. Krüppel-like transcription factors and control of pluripotency , 2010, BMC Biology.
[29] T. Russo,et al. Direct targets of Klf5 transcription factor contribute to the maintenance of mouse embryonic stem cell undifferentiated state , 2010, BMC Biology.
[30] Zhongmei Zhou,et al. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation. , 2010, Cancer research.
[31] Varda Rotter,et al. Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis. , 2010, Discovery medicine.
[32] Shuangxi Li,et al. The Fbw7/Human CDC4 Tumor Suppressor Targets Proproliferative Factor KLF5 for Ubiquitination and Degradation through Multiple Phosphodegron Motifs* , 2010, The Journal of Biological Chemistry.
[33] V. Yang,et al. Krüppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations , 2010, Molecular Cancer.
[34] Mei Han,et al. Angiotensin II stimulates KLF5 phosphorylation and its interaction with c-Jun leading to suppression of p21 expression in vascular smooth muscle cells. , 2009, Journal of biochemistry.
[35] Zhongmei Zhou,et al. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1 , 2009, Oncogene.
[36] Qianben Wang,et al. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro. , 2009, Molecular endocrinology.
[37] P. Guo,et al. Opposing Effects of KLF5 on the Transcription of MYC in Epithelial Proliferation in the Context of Transforming Growth Factor β , 2009, The Journal of Biological Chemistry.
[38] O. Stoeltzing,et al. Up-Regulation of Krüppel-Like Factor 5 in Pancreatic Cancer Is Promoted by Interleukin-1β Signaling and Hypoxia-Inducible Factor-1α , 2009, Molecular Cancer Research.
[39] Ceshi Chen,et al. Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases , 2009, Cellular and Molecular Life Sciences.
[40] V. Yang,et al. Haploinsufficiency of Krüppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine. , 2009, Cancer research.
[41] K. Zhao,et al. Acetylation of KLF5 Alters the Assembly of p15 Transcription Factors in Transforming Growth Factor-β-mediated Induction in Epithelial Cells* , 2009, The Journal of Biological Chemistry.
[42] Zhongmei Zhou,et al. KLF5 Promotes Breast Cell Survival Partially through Fibroblast Growth Factor-binding Protein 1-pERK-mediated Dual Specificity MKP-1 Protein Phosphorylation and Stabilization* , 2009, The Journal of Biological Chemistry.
[43] Mei Han,et al. Synthetic retinoid Am80 inhibits interaction of KLF5 with RARα through inducing KLF5 dephosphorylation mediated by the PI3K/Akt signaling in vascular smooth muscle cells , 2009, FEBS letters.
[44] Toru Suzuki,et al. Krüppel-like Factor 5 Shows Proliferation-specific Roles in Vascular Remodeling, Direct Stimulation of Cell Growth, and Inhibition of Apoptosis* , 2009, Journal of Biological Chemistry.
[45] Mei Han,et al. Synthetic retinoid Am80 inhibits interaction of KLF5 with RAR¦Á through inducing KLF5 dephosphorylation mediated by the PI3K/Akt signaling in vascular smooth muscle cells , 2009 .
[46] Xiaohui Zhang,et al. Pro-proliferative Factor KLF5 Becomes Anti-proliferative in Epithelial Homeostasis upon Signaling-mediated Modification* , 2009, Journal of Biological Chemistry.
[47] V. Yang,et al. SUMOylation Regulates Nuclear Localization of Krüppel-like Factor 5* , 2008, Journal of Biological Chemistry.
[48] Kozo Nakamura,et al. Krüppel-like Factor 5 Causes Cartilage Degradation through Transactivation of Matrix Metalloproteinase 9* , 2008, Journal of Biological Chemistry.
[49] J. Whitsett,et al. Kruppel-like factor 5 is required for perinatal lung morphogenesis and function , 2008, Development.
[50] Marie-Pier Tétreault,et al. Krüppel-like Factor 5 Controls Keratinocyte Migration via the Integrin-linked Kinase* , 2008, Journal of Biological Chemistry.
[51] Mitsuru Ohsugi,et al. SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-δ , 2008, Nature Medicine.
[52] Toru Suzuki,et al. Acyclic retinoid inhibits functional interaction of transcription factors Krüppel‐like factor 5 and retinoic acid receptor‐alpha , 2008, FEBS letters.
[53] V. Yang,et al. Krüppel-like factor 5 mediates transmissible murine colonic hyperplasia caused by Citrobacter rodentium infection. , 2008, Gastroenterology.
[54] O. Shirakawa,et al. Expression of Kruppel-like factor 5 gene in human brain and association of the gene with the susceptibility to schizophrenia , 2008, Schizophrenia Research.
[55] Sheng Zhong,et al. A core Klf circuitry regulates self-renewal of embryonic stem cells , 2008, Nature Cell Biology.
[56] K. Soo,et al. Kruppel-like factor 5 modulates p53-independent apoptosis through Pim1 survival kinase in cancer cells , 2008, Oncogene.
[57] M. Horikoshi,et al. Promoter Region-Specific Histone Incorporation by the Novel Histone Chaperone ANP32B and DNA-Binding Factor KLF5 , 2007, Molecular and Cellular Biology.
[58] V. Yang,et al. The diverse functions of Krüppel‐like factors 4 and 5 in epithelial biology and pathobiology , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.
[59] J. Tobias,et al. Overexpression of Kruppel-like factor 5 in esophageal epithelia in vivo leads to increased proliferation in basal but not suprabasal cells. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[60] M. Horikoshi,et al. Functional Interaction between the Transcription Factor Krüppel-like Factor 5 and Poly(ADP-ribose) Polymerase-1 in Cardiovascular Apoptosis* , 2007, Journal of Biological Chemistry.
[61] Zhongmei Zhou,et al. Proteasomal degradation of the KLF5 transcription factor through a ubiquitin‐independent pathway , 2007, FEBS letters.
[62] V. Yang,et al. Protein Inhibitor of Activated STAT1 Interacts with and Up-regulates Activities of the Pro-proliferative Transcription Factor Krüppel-like Factor 5* , 2007, Journal of Biological Chemistry.
[63] H. Nakagawa,et al. Krüppel‐like factor 5 activates MEK/ERK signaling via EGFR in primary squamous epithelial cells , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[64] I. Tomlinson,et al. Colorectal cancer and genetic alterations in the Wnt pathway , 2006, Oncogene.
[65] V. Jaks,et al. Epidermal and craniofacial defects in mice overexpressing Klf5 in the basal layer of the epidermis , 2006, Journal of Cell Science.
[66] R. Bafford,et al. Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia. , 2006, Surgery.
[67] H. Frierson,et al. Increased cytoplasmic localization of KLF5 in prostate cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] Lily Yang,et al. KLF5 Interacts with p53 in Regulating Survivin Expression in Acute Lymphoblastic Leukemia* , 2006, Journal of Biological Chemistry.
[69] G. Heinze,et al. Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer , 2006, Clinical Cancer Research.
[70] J. Simons,et al. KLF5 promotes cell proliferation and tumorigenesis through gene regulationin the TSU‐Pr1 human bladder cancer cell line , 2006, International journal of cancer.
[71] V. Yang,et al. Krüppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells , 2006, Nucleic acids research.
[72] J. Simons,et al. Human Kruppel-like Factor 5 Is a Target of the E3 Ubiquitin Ligase WWP1 for Proteolysis in Epithelial Cells* , 2005, Journal of Biological Chemistry.
[73] K. Fujiu,et al. Synthetic Retinoid Am80 Suppresses Smooth Muscle Phenotypic Modulation and In-Stent Neointima Formation by Inhibiting KLF5 , 2005, Circulation research.
[74] H. Chao,et al. KLF4 and KLF5 regulate proliferation, Apoptosis and invasion in esophageal cancer cells , 2005, Cancer biology & therapy.
[75] J. Simons,et al. Ubiquitin–proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells , 2005, Oncogene.
[76] M. Horikoshi,et al. The Deacetylase HDAC1 Negatively Regulates the Cardiovascular Transcription Factor Krüppel-like Factor 5 through Direct Interaction* , 2005, Journal of Biological Chemistry.
[77] V. Yang,et al. All‐trans retinoic acid inhibits proliferation of intestinal epithelial cells by inhibiting expression of the gene encoding Krüppel‐like factor 5 , 2004, FEBS letters.
[78] V. Yang,et al. Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras , 2004, Oncogene.
[79] Zhongmei Zhou,et al. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells. , 2004, Gene.
[80] D. Tan,et al. Intestinal Tumor Progression Is Associated with Altered Function of KLF5* , 2004, Journal of Biological Chemistry.
[81] F. Stewart,et al. Microarray analysis to identify molecular mechanisms of radiation-induced microvascular damage in normal tissues. , 2004, International journal of radiation oncology, biology, physics.
[82] Toru Suzuki,et al. Regulation of Platelet-derived Growth Factor-A Chain by Krüppel-like Factor 5* , 2004, Journal of Biological Chemistry.
[83] A. Kimura,et al. Positive and Negative Regulation of the Cardiovascular Transcription Factor KLF5 by p300 and the Oncogenic Regulator SET through Interaction and Acetylation on the DNA-Binding Domain , 2003, Molecular and Cellular Biology.
[84] R. Doty,et al. Regulation of T-cell receptor D beta 1 promoter by KLF5 through reiterated GC-rich motifs. , 2003, Blood.
[85] C. Teng,et al. Phosphorylation of Kruppel-like factor 5 (KLF5/IKLF) at the CBP interaction region enhances its transactivation function. , 2003, Nucleic acids research.
[86] R. Vessella,et al. KLF5 is frequently deleted and down‐regulated but rarely mutated in prostate cancer , 2003, The Prostate.
[87] R. Urrutia,et al. Sp1- and Krüppel-like transcription factors , 2003, Genome Biology.
[88] Ceshi Chen,et al. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer , 2002, Oncogene.
[89] H. Nishimatsu,et al. Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling , 2002, Nature Medicine.
[90] I. Sur,et al. Human Krüppel-like factor5/KLF5: synergy with NF-kappaB/Rel factors and expression in human skin and hair follicles. , 2002, European journal of cell biology.
[91] Toru Suzuki,et al. Phenotypic Modulation of Vascular Smooth Muscle Cells , 2001, Annals of the New York Academy of Sciences.
[92] J. Bieker. Krüppel-like Factors: Three Fingers in Many Pies* , 2001, The Journal of Biological Chemistry.
[93] J. Bieker,et al. Unanticipated Repression Function Linked to Erythroid Krüppel-Like Factor , 2001, Molecular and Cellular Biology.
[94] Vincent W. Yang,et al. Intestinal-enriched Krüppel-like Factor (Krüppel-like Factor 5) Is a Positive Regulator of Cellular Proliferation* , 2001, The Journal of Biological Chemistry.
[95] Christopher P. Regan,et al. Positive- and Negative-acting Krüppel-like Transcription Factors Bind a Transforming Growth Factor β Control Element Required for Expression of the Smooth Muscle Cell Differentiation Marker SM22α in Vivo * , 2000, The Journal of Biological Chemistry.
[96] E. Gillanders,et al. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[97] H. Frierson,et al. Deletion at 13q21 is associated with aggressive prostate cancers. , 2000, Cancer research.
[98] R. Nagai,et al. Transcriptional Regulation of Smooth Muscle Phenotypic Modulation , 2000, Annals of the New York Academy of Sciences.
[99] R. Nagai,et al. Transcriptional activation of the zinc finger transcription factor BTEB2 gene by Egr-1 through mitogen-activated protein kinase pathways in vascular smooth muscle cells. , 1999, Circulation research.
[100] K Autio,et al. DNA copy number losses in human neoplasms. , 1999, The American journal of pathology.
[101] Y. Yazaki,et al. BTEB2, a Krüppel-like transcription factor, regulates expression of the SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. , 1999, Circulation research.
[102] M. Conkright,et al. A gene encoding an intestinal-enriched member of the Krüppel-like factor family expressed in intestinal epithelial cells. , 1999, Nucleic acids research.
[103] O. Gotoh,et al. Transcriptional activation domain of human BTEB2, a GC box-binding factor. , 1997, Journal of biochemistry.
[104] D. Shibata,et al. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation , 1994, Nature Genetics.
[105] Y Fujii-Kuriyama,et al. cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2. , 1993, Nucleic acids research.
[106] Anna L. Brown,et al. The granulocyte-associated transcription factor Krüppel-like factor 5 is silenced by hypermethylation in acute myeloid leukemia. , 2012, Leukemia research.
[107] Zhongmei Zhou,et al. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis. , 2012, Carcinogenesis.
[108] Mei Han,et al. Krüppel-like factor (KLF) 5 mediates cyclin D1 expression and cell proliferation via interaction with c-Jun in Ang II-induced VSMCs , 2010, Acta Pharmacologica Sinica.
[109] Ceshi Chen. Regulation of Krüpple-like factor 5 by targeted protein degradation. , 2010, Methods in molecular biology.
[110] K. Zhao,et al. Estrogen‐induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER‐positive breast cancer cells , 2010, International journal of cancer.
[111] Min-young Lee,et al. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells. , 2009, The Biochemical journal.
[112] V. Yang,et al. Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. , 2008, Gastroenterology.
[113] S. Akira,et al. Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. , 2005, Cell metabolism.
[114] G. Owens,et al. Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. , 2000, The Journal of biological chemistry.
[115] A. Aventín,et al. Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies. , 1998, Blood.